Mediphage Bioceuticals Inc.

📍 Toronto, Canada🗓 Founded 2016👥 9 employees
Biotechnology🌐 mediphage.bio
Website LinkedIn
Mediphage Bioceuticals is a genetic medicine company focused on developing safe, effective and accessible transgene delivery platforms to unlock the power of personalized, redoseable genetic medicine. Our flagship technology, ministring DNA, is the safest transgene delivery vector on the market that does not compromise effectiveness and can be produced at a fraction of the cost of competing solutions. Unlike conventional viral and non-viral vectors, ministring DNA has a linear covalently closed “string” topology, allowing for customizable and redoseable delivery of genes into cells for gene therapy, cell engineering and gene editing. Currently, Mediphage Bioceuticals is focusing its in-house efforts on applying ministring DNA as a therapeutic solution for Stargardt Disease.
0
Total investors
0
Early stage
0
Mid stage
0
Late stage
2016
Founded

Investors

0 investors
All
Early stage
Mid stage
Late stage
No investors in this category
Frequently asked questions
When was Mediphage Bioceuticals Inc. founded?
Mediphage Bioceuticals Inc. was founded in 2016.
What industry is Mediphage Bioceuticals Inc. in?
Mediphage Bioceuticals Inc. operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Mediphage Bioceuticals Inc. based?
Mediphage Bioceuticals Inc. is headquartered in Toronto, Canada.